SOX9 and osteoarthritis: While Fisetin decreased the expression of SOX9 in human osteoarthritis chondrocytes, combining dasatinib and quercetin increased the number of SOX9+ chondrogenic progenitor cells in an in vivo intermittent hydrostatic pressure model in the posttraumatic osteoarthritis rats [166,167].